Literature DB >> 22476605

The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision.

Robert D Ross1.   

Abstract

Accurate grading of the presence and severity of heart failure (HF) signs and symptoms in infants and children remains challenging. It has been 25 years since the Ross classification was first used for this purpose. Since then, several modifications of the system have been used and others proposed. New evidence has shown that in addition to signs and symptoms, data from echocardiography, exercise testing, and biomarkers such as N-terminal pro-brain natriuretic peptide (NT-proBNP) all are useful in stratifying outcomes for children with HF. It also is apparent that grading of signs and symptoms in children is dependent on age because infants manifest HF differently than toddlers and older children. This review culminates in a proposed new age-based Ross classification for HF in children that incorporates the most useful data from the last two decades. Testing of this new system will be important to determine whether an age-stratified scoring system can unify the way communication of HF severity and research on HF in children is performed in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476605     DOI: 10.1007/s00246-012-0306-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  24 in total

1.  Grading the graders of congestive heart failure in children.

Authors:  R D Ross
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

2.  A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease.

Authors:  C Reithmann; D Reber; R Kozlik-Feldmann; H Netz; G Pilz; A Welz; K Werdan
Journal:  Eur J Pharmacol       Date:  1997-07-02       Impact factor: 4.432

3.  Selection of patients for heart transplantation in the current era of heart failure therapy.

Authors:  Javed Butler; Ghazanfar Khadim; Kimberly M Paul; Stacy F Davis; Marvin W Kronenberg; Don B Chomsky; Richard N Pierson; John R Wilson
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

4.  BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.

Authors:  Scott R Auerbach; Marc E Richmond; Jacqueline M Lamour; Elizabeth D Blume; Linda J Addonizio; Robert E Shaddy; Lynn Mahony; Elfriede Pahl; Daphne T Hsu
Journal:  Circ Heart Fail       Date:  2010-06-23       Impact factor: 8.790

5.  Usefulness of mitral regurgitation as a marker of increased risk for death or cardiac transplantation in idiopathic dilated cardiomyopathy in children.

Authors:  Fernanda P Fernandes; Cedric Manlhiot; Brian W McCrindle; Luc Mertens; Paul F Kantor; Mark K Friedberg
Journal:  Am J Cardiol       Date:  2011-03-04       Impact factor: 2.778

6.  The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.

Authors:  Masaya Sugimoto; Hiromi Manabe; Kouichi Nakau; Akiko Furuya; Kasumi Okushima; Hiroaki Fujiyasu; Fujio Kakuya; Kazutomo Goh; Kenji Fujieda; Hiroki Kajino
Journal:  Circ J       Date:  2010-04-06       Impact factor: 2.993

7.  Grading the severity of congestive heart failure in infants.

Authors:  R D Ross; R O Bollinger; W W Pinsky
Journal:  Pediatr Cardiol       Date:  1992-04       Impact factor: 1.655

8.  Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters.

Authors:  Stephanie Läer; Thomas S Mir; Frederike Behn; Michele Eiselt; Hasso Scholz; Andrea Venzke; Bernd Meibohm; Jochen Weil
Journal:  Am Heart J       Date:  2002-05       Impact factor: 4.749

9.  The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children.

Authors:  D Connolly; M Rutkowski; M Auslender; M Artman
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

10.  Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease.

Authors:  J R Wu; H R Chang; T Y Huang; C H Chiang; S S Chen
Journal:  Am J Cardiol       Date:  1996-01-15       Impact factor: 2.778

View more
  32 in total

Review 1.  Heart failure in children in tropical regions.

Authors:  Manojkumar Rohit; Ankur Gupta; K K Talwar
Journal:  Curr Heart Fail Rep       Date:  2013-12

2.  Galectin-3 in Children with Chronic Heart Failure with Normal and Reduced Ejection Fraction: Relationship to Disease Severity.

Authors:  Alyaa Amal Kotby; Omneya Ibrahim Youssef; Mohamed Omar Elmaraghy; Osama Salah El Sharkawy
Journal:  Pediatr Cardiol       Date:  2016-11-11       Impact factor: 1.655

3.  The Association Between Cardiac Biomarker NT-proBNP and 30-Day Readmission or Mortality After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; JoAnna Leyenaar; Luca Vricella; Jeffrey P Jacobs; Heather Thiessen-Philbrook; Chirag Parikh; Jason H Greenberg; Jeremiah R Brown
Journal:  World J Pediatr Congenit Heart Surg       Date:  2019-07

4.  Safety and efficacy of the endothelin receptor antagonist macitentan in pediatric pulmonary hypertension.

Authors:  Sabrina Schweintzger; Martin Koestenberger; Axel Schlagenhauf; Gernot Grangl; Ante Burmas; Stefan Kurath-Koller; Mirjam Pocivalnik; Hannes Sallmon; Daniela Baumgartner; Georg Hansmann; Andreas Gamillscheg
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

5.  Predictive Value of Plasma Copeptin Level in Children with Acute Heart Failure.

Authors:  Doaa El Amrousy; Dina Abdelhai; Mohammed Nassar
Journal:  Pediatr Cardiol       Date:  2022-05-09       Impact factor: 1.838

6.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

7.  Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.

Authors:  Niccolò Maurizi; Silvia Passantino; Gaia Spaziani; Francesca Girolami; Anna Arretini; Mattia Targetti; Iva Pollini; Alessia Tomberli; Silvia Pradella; Giovanni Battista Calabri; Veronica Vinattieri; Bruno Bertaccini; Ornella Leone; Luciano De Simone; Claudio Rapezzi; Niccolò Marchionni; Franco Cecchi; Silvia Favilli; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

8.  Pediatric Diastolic Heart Failure: Clinical Features Description of 421 Cases.

Authors:  Bo Pan; Di Hu; Huichao Sun; Tiewei Lv; Wangguo Xu; Jie Tian
Journal:  Front Pediatr       Date:  2022-05-02       Impact factor: 3.418

9.  Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria.

Authors:  Viktoria H M Weixler; Peter Kramer; Peter Murin; Olga Romanchenko; Mi-Young Cho; Stanislav Ovroutski; Michael Hübler; Felix Berger; Joachim Photiadis
Journal:  Pediatr Cardiol       Date:  2022-02-11       Impact factor: 1.838

10.  A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.

Authors:  Muhammad Fawad Rasool; Feras Khalil; Stephanie Läer
Journal:  Clin Pharmacokinet       Date:  2015-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.